Skip to main content

Blog

Catch up on what’s happening at PPMD’s 2023 Annual Conference: Day 3

...

Catch Up on What’s Happening at PPMD’s 2023 Annual Conference: Day 2

...

Catch Up on What’s Happening at PPMD’s 2023 Annual Conference: Day 1

...

Italfarmaco Group Announces NDA Accepted for Givinostat

...

Edgewise Therapeutics announces positive topline 12-month data from EDG-5506 ARCH study

...

FDA grants approval via accelerated approval pathway to ELEVIDYS: First-ever gene therapy for individuals with Duchenne ages 4-5

...

Santhera announces exclusive North America license agreement with Catalyst Pharmaceuticals for vamorolone

...

Thanks to you PPMD continues forward in all areas of support

...

WATCH: ENVISION Study Update With Sarepta Therapeutics (Webinar Recording)

...

PPMD Announces Pediatric Certified Duchenne Care Center at Norton Children’s Hospital

...